Clinical Trial Update: A Multi-Center Study to Evaluate the Safety and Efficacy of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Adults With Moderate-to-Severe Crohn's Disease [Phase 2]

View source ↗

Summary

Phase 2 study evaluating intravenous human placenta-derived cells (PDA001) for adults with moderate-to-severe Crohn's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• PDA001

Snippet

Sponsor: Celularity Incorporated | Conditions: Crohn's Disease | Phase 2 | Status: COMPLETED